Trial NCT02131506

View at ClinicalTrials.gov 
Org. Study IDs: IRST174.01
Secondary IDs: 2009-012996-82

Last trial update was posted on 2016-02-02

MeSH Interventions

Doxorubicin Lapatinib Liposomal doxorubicin

MeSH Conditions

Breast Neoplasms Neoplasms

Other Conditions

HER-2 Positive Breast Cancer Malignant Neoplasm of Breast

Stopping Reasons

Safety reasons

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID